Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12695097 | 0.83 | CYP2D6 (0.34) | — | |
| SCHEMBL14486633 | 0.83 | CYP2D6 (0.34) | — | |
| SCHEMBL131689 | 0.83 | — | — | |
| SCHEMBL18889771 | 0.83 | SLC1A3 (0.32) | — | |
| SCHEMBL18889903 | 0.83 | SLC1A3 (0.32) | — | |
| Ammonia Solution, Strong SCHEMBL9287 | 0.81 | — | — | |
| SCHEMBL20265985 | 0.81 | LMNA (0.35) | — | |
| SCHEMBL13850462 | 0.79 | CHRM2 (0.32) | — | |
| SCHEMBL10327132 | 0.78 | HCRTR2 (0.41) | HCRTR2 | |
| SCHEMBL19865681 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365556-A1 | N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE | PLIANT THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| US-3993604-A | ORGANOLEPTIC, PERFUMES, FLAVORS | FIRMENICH S.A. (CH) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365556-A1 | N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE | ITGA1, ITGB1, ITGAL | HCRTR2 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.